Phage Technologies’ $30 million round funding

Carey and Wilson Sonsini Goodrich & Rosati advised Phage Technologies.
Magliona Abogados and Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Kaszek Ventures on the deal

Phage Technologies secured a $30 million financing in its second round funding with Kaszek Ventures and Humboldt.

Phage Technologies has created and developed a platform from discovery to industrial production of new antibacterial compounds based on bacteriophages. These compounds are microscopic bacterial viruses able to infect specifically targeted bacteria.

Carey advised Phage Technologies with Francisco Guzmán (Picture), Constanza Rivera and Andrés Latorre.

Wilson Sonsini Goodrich & Rosati advised Phage Technologies in US.

Magliona Abogados advised Kaszek Ventures with Claudio Magliona, Carolina Abarca and Karla Cid.

Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Kaszek Ventures in US.

Involved fees earner: Francisco Guzmán – Carey; Andrés Latorre – Carey; Constanza Rivera – Carey; Bradley Krack – Gunderson Dettmer Stough Villeneuve Franklin & Hachigian; Carolina Abarca – Magliona Abogados; Karla Cid – Magliona Abogados; Claudio Magliona M. – Magliona Abogados;

Law Firms: Carey; Gunderson Dettmer Stough Villeneuve Franklin & Hachigian; Magliona Abogados;

Clients: Kaszek Venture; Phage Technologies S.A;